FDA Inspection 551865 — Robert Boissoneault Oncology Institute
The FDA completed an inspection of Robert Boissoneault Oncology Institute on Dec 12, 2008 in Ocala, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 12, 2008
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ocala, FL (United States)